Basel Medical Group Ltd (NASDAQ:BMGL) Short Interest Update

Basel Medical Group Ltd (NASDAQ:BMGL – Get Free Report) was the target of a large drop in short interest in the month of July. As of July 31st, there was short interest totaling 15,664 shares, a drop of 51.9% from the July 15th total of 32,559 shares. Based on an average trading volume of 7,540 shares, the days-to-cover ratio is presently 2.1 days. Currently, 1.0% of the company’s stock are sold short.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings downgraded Basel Medical Group from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Monday, August 3rd. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has a consensus rating of “Sell”.

Get Basel Medical Group alerts:

Get Our Latest Report on Basel Medical Group

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Marex Group plc purchased a new stake in shares of Basel Medical Group during the second quarter valued at $25,000. Virtu Financial LLC grew its stake in Basel Medical Group by 108.8% during the 3rd quarter. Virtu Financial LLC now owns 33,786 shares of the company’s stock valued at $61,000 after purchasing an additional 17,608 shares during the last quarter. Finally, Citadel Advisors LLC acquired a new position in shares of Basel Medical Group in the third quarter valued at about $169,000.

Basel Medical Group Stock Down 7.1%

BMGL stock traded down $0.38 on Tuesday, hitting $4.88. 2,669 shares of the company’s stock were exchanged, compared to its average volume of 26,934. Basel Medical Group has a 12-month low of $4.17 and a 12-month high of $25.80. The firm has a 50 day moving average price of $6.36 and a two-hundred day moving average price of $7.12. The company has a quick ratio of 1.83, a current ratio of 1.88 and a debt-to-equity ratio of 0.93.

Basel Medical Group (NASDAQ:BMGL – Get Free Report) last issued its quarterly earnings results on Friday, June 26th. The company reported $0.01 earnings per share for the quarter. The business had revenue of $3.21 million during the quarter.

Basel Medical Group Company Profile

(Get Free Report)

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.

Featured Stories

• Five stocks we like better than Basel Medical Group
• The AI Boom Is Turning This Cable Maker Into a Stock to Watch
• A Star Investor Just Trimmed Amazon—Here’s What It means
• Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
• Home Depot Analysts See a Path to $375 and Beyond

Receive News & Ratings for Basel Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basel Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.